Loading
Total declarations
Companies
▲ Purchases (12 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Sept 2026 for HLB제약. Read the official filing
Insider track record
Disclosed buys
12
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
12
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- +63.9%Entry ₩11,920 · Close at T+365 ₩19,540
- -14.9%Entry ₩14,000 · Close at T+365 ₩11,920
- +7.9%Entry ₩11,050 · Close at T+365 ₩11,920
- -11.0%Entry ₩13,600 · Close at T+365 ₩12,100
- -11.0%Entry ₩13,600 · Close at T+365 ₩12,100
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Hlb생명과학: trading record in brief
Hlb생명과학 discloses dealings in 2 companies, chiefly HLB제약 and HLB생명과학. Over a trading history stretching from 25 February 2021 to 28 September 2026, the count stands at 69 filings.
The open-market record is one-sided, with 12 purchases and not one sale. No amount is published for 12 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2026 alone, the filings show 1 purchase and no sales.
Across 10 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The newest entry dates from 28 September 2026: a transaction, in HLB제약. The most recent open-market purchase was published on 26 August 2026, 53 days ago. Filings reach the DART (FSS) feed a median of 5 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Companies and markets linked to Hlb생명과학
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations69 total
25 of 69 declarations
